![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhBmAMkt3ZtjwnH1Vj-kvkVU_odo91ukJgqScbsTFPgq5PWTfXgc-w_64VutPAjlYRoDRs0mJhudID1GNhKtDWrd_lajL8QiKsykB2F7MQ6tHh4ibfDH4dI1jdYg8gqk9xyajQ89mPp5aI/s320/post+amy.jpg)
A story by James Goodman and Sean Lahman builds on an ongoing journalistic investigation on the financial ties between research universities and pharmaceutical companies. Reports from a small Rochester paper, the Democrat and Chronicle, have revealed the extent to which local university doctors are selling health-related “professional education programs” to medical conglomerates. The report revealed that “only a handful of states require pharmaceutical companies to disclose payments to physicians.” Therefore, with little or no formal regulation, a university doctor moonlighting for pharmaceutical company becomes a question of individual ethics: an issue tainted by six figure compensations from medical corporations, where the threshold for acceptable behavior may not draw a clear boundary to separate doctors from industry influence.
Read more on this investigation at:
http://www.democratandchronicle.com/article/20100718/NEWS01/7180358
No hay comentarios:
Publicar un comentario